Inhibition of TGM2 enhances cisplatin sensitivity in MSH2-deficient bladder cancer. - Wei W; Xiao X; Ren C; Zhang H; Sun J; Wang M; Wang L; Chen H; Jiang G; Huang C (Cell death discovery, 2026)